Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists have transformed weight management for millions of people, with clinical trials showing average weight loss of 15–22% over 68 weeks. However, many patients feel uncertain about how to initiate this conversation with their healthcare provider. This guide walks you through the steps to confidently request GLP-1 medications and explains how PlexusDx streamlines access to these powerful compounds.

Understand Your Medical Eligibility for GLP-1 Therapy

GLP-1 medications are prescribed for weight management in adults with a BMI of 27 or higher (with at least one weight-related health condition) or a BMI of 30 or higher regardless of other conditions. Before asking your doctor, calculate your BMI and document any related conditions such as type 2 diabetes, hypertension, or sleep apnea. Having this information ready demonstrates you've prepared for the conversation and helps your doctor assess your candidacy quickly.

Your medical history matters significantly in this discussion. Be ready to share your current medications, any previous weight loss attempts, and whether you have a family history of weight-related metabolic disorders. Your doctor will want to know if you've experienced side effects from other medications or if you have any contraindications such as a personal history of medullary thyroid cancer. This transparency allows your healthcare provider to make an informed decision about whether GLP-1 therapy aligns with your overall health profile.

Prepare Your Medical History and Weight Loss Goals

Write down your weight loss journey before your appointment, including previous diets, exercise routines, and what obstacles prevented long-term success. Be specific: instead of saying "I've tried dieting," explain that you struggled with hunger management or lacked sustained energy for workouts. This narrative helps your doctor understand why GLP-1 therapy—which works through appetite suppression and metabolic optimization—might be the right fit for your situation.

Set realistic, measurable goals to discuss with your provider. Rather than stating a target weight, frame your objectives around health markers: reducing blood pressure, improving cholesterol levels, or decreasing reliance on diabetes medication. GLP-1 medications address the underlying metabolic factors that drive weight gain, so emphasizing metabolic health rather than appearance-based goals often resonates better with physicians and strengthens the clinical rationale for treatment.

Ask Specific Questions About GLP-1 Medication Options

During your conversation, ask your doctor which GLP-1 compounds they're familiar with and whether they have preferences based on your health profile. The primary options are semaglutide and tirzepatide, each with distinct mechanisms: semaglutide targets GLP-1 receptors alone, while tirzepatide activates both GLP-1 and GIP receptors for potentially greater effect. Ask about the differences in efficacy, side effect profiles, and which format—injection or oral—aligns with your preferences and lifestyle.

Inquire about your doctor's experience with GLP-1 prescribing, including how they monitor progress and adjust doses. Ask whether they provide ongoing support during treatment, how often you'll have follow-up appointments, and what warning signs or side effects warrant immediate contact. Understanding your doctor's involvement in your care helps you decide whether to work with your primary care physician or seek a specialized weight management provider.

Discuss Prescription, Cost, and Access Options

Once your doctor agrees GLP-1 therapy is appropriate, discuss whether they'll write a prescription and what to do next. Ask if they have preferred pharmacies or if they're willing to work with compounding pharmacies. PlexusDx partners with licensed 503A compounding pharmacies nationwide, offering Semaglutide Injection starting at $149 per month with no insurance requirement and HSA/FSA eligibility. Your dose may need to go up during treatment optimization, but your monthly price remains flat.

If cost is a concern, mention this directly to your doctor. Many patients aren't aware that compounded GLP-1 medications from licensed pharmacies provide a more affordable pathway than branded options, especially for those without insurance coverage. PlexusDx serves all 50 states with no membership fees, making personalized GLP-1 therapy accessible regardless of your insurance status. Ask your doctor if they're open to writing a prescription that you can fill through a direct-access provider, which may offer greater flexibility and transparency around pricing.

Request Genetic Testing for Personalized Treatment Optimization

For patients seeking the most tailored approach, ask your doctor about peptide-pathway genetic testing. PlexusDx offers the Precision Peptide Genetic Test, which analyzes key variants including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 across 14 metabolic pathways. This test identifies how your genetic predispositions affect GLP-1 receptor sensitivity, appetite regulation, and metabolic response—information that guides compound selection and dose strategy.

Genetic insights allow your healthcare team to anticipate which GLP-1 medication may work best for your biology before starting treatment. For example, variations in the GLP1R gene influence how strongly you'll respond to semaglutide versus tirzepatide. While not required for GLP-1 therapy, genetic testing at $99 after your first month provides a data-driven foundation for long-term treatment optimization. Ask your doctor if they'd support incorporating genetic insights into your treatment plan.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What if my doctor says no to GLP-1 medications?

If your primary care doctor declines, ask specifically why and whether those concerns can be addressed with additional testing or specialist consultation. You may also seek a second opinion from a weight management specialist or telemedicine provider experienced in GLP-1 prescribing. PlexusDx works with patients whose doctors have written prescriptions; if you lack a willing prescriber, exploring specialized weight management clinics in your area is the appropriate next step.

How much weight loss should I expect from GLP-1 medications?

Clinical trials demonstrate average weight loss of 15–22% of body weight over one year, though individual results vary based on genetics, lifestyle, and medication choice. Tirzepatide typically produces slightly greater weight loss than semaglutide due to its dual GLP-1/GIP mechanism. Your doctor can discuss realistic timelines and help set expectations based on similar patients they've treated.

Do I need insurance to access GLP-1 medications through PlexusDx?

No. PlexusDx serves all 50 states with no insurance requirement, no membership fees, and direct pricing starting at $149 per month for Semaglutide Injection. Your prescription can be filled through PlexusDx-partnered licensed 503A compounding pharmacies, and payments are HSA/FSA eligible for additional savings.

What are the most common side effects of GLP-1 medications?

Nausea, constipation, and reduced appetite are most frequently reported, particularly during the initial dose escalation phase. These effects typically diminish as your body adapts over 2–4 weeks. Serious side effects are rare but include pancreatitis or allergic reactions; your doctor will monitor for warning signs and adjust treatment if needed.

Can genetic testing help predict which GLP-1 medication will work better for me?

Yes. PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to assess your receptor sensitivity and metabolic predispositions across 14 pathways. These insights help your provider select semaglutide or tirzepatide based on your biology rather than trial-and-error, optimizing your response from the start.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves